Pediatric Pharmacokinetics And Safety Study Of Moxidectin
Status:
Withdrawn
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the amount of moxidectin in subjects' blood and to
measure safety. This study will enroll 36 children aged 4 to 11 years (>=12 kg) with or
without Onchocerca volvulus (O volvulus) infection. O volvulus is the nematode, or roundworm,
that causes Onchocerciasis, also known as river blindness. Each subject will receive a single
dose of 4 mg moxidectin (orally administered) and will be followed inpatient from screening
through day 13 and as outpatients through month 6. The study will take place at a single
research center.